Filing summary
Registrant identity: The supplied filing is Brilliant Acquisition Corporation’s Form 10-Q, not a filing under the name T3 Defense Inc. The filing covers the quarter and nine months ended September 30, 2022; financial statements are unaudited.
Business context
Brilliant is a British Virgin Islands blank-check company seeking a business combination. It had no operating revenue or operations apart from formation, public-company costs, and its acquisition search. On February 22, 2022, it agreed to combine with Nukkleus Inc.; the filing does not report completion of that transaction.
Financial results and liquidity
| Metric | 2022 period | Comparable 2021 period |
|---|---|---|
| Revenue | None | None |
| Operating costs | Three months: $480,867; nine months: $1,094,728 | Three months: $153,337; nine months: $260,315 |
| Net loss | Three months: $578,753; nine months: $1,074,579 | Three months: $124,611; nine months: $166,329 |
| Basic and diluted loss per share | Three months: $0.13; nine months: $0.20 | Three months: $0.02; nine months: $0.03 |
| Operating cash used | Nine months: $1,054,509 | Nine months: $208,455 |
At September 30, 2022, reported total assets were $31.25 million, including $31.17 million held in the Trust Account and $34,044 in operating cash. Current liabilities were $3.82 million, including a $2.61 million related-party promissory note and $870,600 due to a related party. The company reported a $909,424 working-capital deficit excluding Trust Account assets, derivative warrant liabilities of $225,280, and shareholders’ deficit of $3.96 million. Profit margins are not meaningful because the company had no revenue.
Nine-month investing cash inflow of $47.39 million reflected withdrawal of the Trust Account investments; financing cash outflow was $15.41 million, chiefly redemptions of public shares. The filing reports $31.17 million remaining in the Trust Account at quarter-end, classified as ordinary shares subject to possible redemption.
Changes, outlook, and risks
- Net losses rose substantially versus 2021, alongside higher operating costs. The nine-month increase in fair value of warrant liabilities was $44,801, compared with a $90,517 decrease in 2021; this noncash valuation movement affected reported results.
- Shareholders redeemed 1,659,073 shares during the first nine months of 2022 for approximately $17.27 million. After quarter-end, shareholders approved a further extension and redeemed 2,375,991 shares for approximately $25.18 million, about $10.60 per share.
- The October 2022 extension moved the business-combination deadline to November 23, 2022, with possible monthly extensions through January 23, 2023, subject to deposits of $22,600 per month. The company disclosed substantial doubt about its ability to continue as a going concern, citing limited operating cash, its working-capital deficit, and the approaching deadline. Sponsor or other financing is possible but not committed.
- Management reported material weaknesses in internal control over financial reporting concerning accounting for warrants and redeemable shares, and classification of extension deposits. Remediation efforts were planned, but management gave no assurance they would be effective.
- The filing identifies COVID-19, the war in Ukraine and related sanctions, market volatility, financing availability, and failure to complete a business combination on time as risks. No quantified forecast or operating guidance is provided.
Investor verification priorities
- Confirm the intended issuer: the supplied document identifies Brilliant Acquisition Corporation, not T3 Defense Inc.
- Check the latest status of the Nukkleus transaction, extension deadlines, shareholder redemptions, and Trust Account balance; significant redemptions occurred after quarter-end.
- Assess the company’s financing and liquidation plans in light of the going-concern warning and lack of committed additional funding.
- Review the material weaknesses, proposed remediation, and any subsequent reporting on control effectiveness.